(Q39267922)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21470282%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

title

Glucagonoma and the glucagonoma syndrome - cumulative experience with an elusive endocrine tumour (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21470282%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21470282%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

author name string

Roy Eldor

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21470282%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Merav Fraenkel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21470282%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Victoria Doviner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21470282%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Asher Salmon

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21470282%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

David J Gross

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21470282%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

publication date

1 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21470282%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

published in

Clinical Endocrinology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21470282%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

volume

74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21470282%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21470282%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

page(s)

593-598

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21470282%20AND%20SRC:MED&resulttype=core&format=json

Glucagonomas/diabetico-dermatogenic syndrome (DDS): a statistical evaluation of 407 reported cases.

27 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03967.X

Malign cystic glucagonoma presented with diabetic ketoacidosis: case report with an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03967.X

Reversible dilated cardiomyopathy associated with glucagonoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03967.X

Dramatic efficacy of chemotherapy with 5-fluorouracil and dacarbazine in a patient with metastatic glucagonoma and cardiac insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03967.X

The glucagonoma syndrome and necrolytic migratory erythema: a clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03967.X

Population-based study of islet cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03967.X

Cervical metastases of glucagonoma in a patient with multiple endocrine neoplasia type 1: report of a case

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03967.X

Microadenomatosis of the endocrine pancreas in patients with and without the multiple endocrine neoplasia type 1 syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03967.X

Is glucagonoma of the pancreas a curable disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03967.X

Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03967.X

Plasma immunoreactive glucagon fractions in four cases of glucagonoma: Increased “Large glucagon — immunoreactivity”

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03967.X

TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03967.X

Surgical treatment of endocrine pancreatic tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03967.X

Somatostatin analogues in the treatment of endocrine tumors of the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03967.X

Octreotide (SMS 201-995) in the treatment of metastatic glucagonoma: report of one case and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03967.X

Peptide-receptor radionuclide therapy for endocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03967.X

Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03967.X

Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03967.X

Outcome of treating advanced neuroendocrine tumours with radiolabelled somatostatin analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03967.X